Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

Sankar Jagadeeshan; Ganesh Venkatraman; Suresh K. Rayala

doi:10.1080/14728222.2016.1239719

Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

Sankar Jagadeeshan
, Ganesh Venkatraman
, Suresh K. Rayala

Research output: Contribution to journal › Editorial

8 Scopus citations

Original language	English
Pages (from-to)	1283-1285
Number of pages	3
Journal	Expert Opinion on Therapeutic Targets
Volume	20
Issue number	11
DOIs	https://doi.org/10.1080/14728222.2016.1239719
State	Published - 1 Nov 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Pak1
Pak1 inhibitors
gemcitabine resistance
pancreatic adenocarcinoma

ASJC Scopus subject areas

Molecular Medicine
Pharmacology
Drug Discovery
Clinical Biochemistry

Access to Document

10.1080/14728222.2016.1239719

Cite this

@article{e64b049298c8448095f37d62f440762c,

title = "Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer",

keywords = "Pak1, Pak1 inhibitors, gemcitabine resistance, pancreatic adenocarcinoma",

author = "Sankar Jagadeeshan and Ganesh Venkatraman and Rayala, \{Suresh K.\}",

year = "2016",

month = nov,

day = "1",

doi = "10.1080/14728222.2016.1239719",

language = "English",

volume = "20",

pages = "1283--1285",

journal = "Expert Opinion on Therapeutic Targets",

issn = "1472-8222",

publisher = "Taylor and Francis Ltd.",

number = "11",

}

TY - JOUR

T1 - Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

AU - Jagadeeshan, Sankar

AU - Venkatraman, Ganesh

AU - Rayala, Suresh K.

PY - 2016/11/1

Y1 - 2016/11/1

KW - Pak1

KW - Pak1 inhibitors

KW - gemcitabine resistance

KW - pancreatic adenocarcinoma

UR - https://www.scopus.com/pages/publications/84989271445

U2 - 10.1080/14728222.2016.1239719

DO - 10.1080/14728222.2016.1239719

M3 - Editorial

C2 - 27654702

AN - SCOPUS:84989271445

SN - 1472-8222

VL - 20

SP - 1283

EP - 1285

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

IS - 11

ER -

Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this